Mackie Research analyst André Uddin is holding steady with Bellus Health (Bellus Health Stock Quote, Chart, News TSX:BLU) after clinical trial news … [Read more...] about Bellus Health is a double from here, says Mackie Research
Content brought to you by:
The Cantech Letter Life Sciences section is brought to you by Relay Medical Corp. (CSNX:RELA). Relay is in the business of commercializing innovative technologies, protected by issued and pending patents, in the medical diagnostics and research field with an emphasis on In Vitro Diagnostics (IVD) and Point of Care Testing (POCT). Click on the logo for more info...
In a note to clients on Monday, Mackie Research analyst André Uddin changed his rating on Correvio Pharma (Correvio Pharma Stock Quote, Chart, News … [Read more...] about Correvio Pharma shareholders should take the Advanz offer: Mackie
New clinical results from biopharm company IMV (IMV Stock Quote, Chart, News TSX:IMV) signal a less straightforward path to commercialization than … [Read more...] about IMV gets price target cut from Raymond James
Is Pfizer (Pfizer Stock Quote, Chart, News NYSE:PFE) looking interesting here? With its gains over the past couple of years effectively erased now and … [Read more...] about Is it time to sell your Pfizer stock?
After reporting fourth quarter earnings, GW Pharmaceuticals (GW Pharmaceuticals Stock Quote, Chart, News NASDAQ:GWPH) has received a target reduction … [Read more...] about GW Pharmaceuticals keeps “Outperform” rating at AltaCorp Capital
Mackie Research analyst André Uddin is staying bullish on specialty pharma company Theratechnologies (Theratechnologies Stock Quote, Chart, News … [Read more...] about Three reasons to buy Theratechnologies from Mackie Research
Delays at Acasti Pharma (Acasti Pharma Stock Quote, Chart, News TSXV:ACST) have Echelon Wealth Partners analyst Douglas Loe lowering his price target … [Read more...] about Acasti Pharma has price target cut at Echelon
Profound Medical Corp (Profound Medical Corp Stock Quote, Chart, News TSX:PRN) takes top honours from Raymond James analyst Rahul Sarugaser who in a … [Read more...] about Profound Medical gets 2020 “Best Pick” honours from Raymond James
HLS Therapeutics (HLS Therapeutics Stock Quote, Chart, News TSX:HLS) received a target raise from Stifel GMP analyst Justin Keywood on Thursday as a … [Read more...] about HLS Therapeutics has upside left, says Stifel GMP
It was another up and down year for Canadian Life Sciences stocks. In 2018, the downfall of the sector came in the last couple of months. A year … [Read more...] about The Ten Best Performing Canadian Life Sciences Stocks of 2019